162 related articles for article (PubMed ID: 2985239)
1. Elimination of small cell lung cancer cells in vitro from human bone marrow by a monoclonal antibody.
Okabe T; Kaizu T; Ozawa K; Urabe A; Takaku F
Cancer Res; 1985 May; 45(5):1930-3. PubMed ID: 2985239
[TBL] [Abstract][Full Text] [Related]
2. Immunological and pharmacological removal of small cell lung cancer cells from bone marrow autografts.
Humblet Y; Feyens AM; Sekhavat M; Agaliotis D; Canon JL; Symann ML
Cancer Res; 1989 Sep; 49(18):5058-61. PubMed ID: 2548708
[TBL] [Abstract][Full Text] [Related]
3. [Application of monoclonal antibodies to diagnosis and treatment of small cell lung cancers].
Fujisawa M; Okabe T
Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 2-1):984-9. PubMed ID: 2839119
[TBL] [Abstract][Full Text] [Related]
4. Selective cytotoxicity of the SM1 monoclonal antibody towards small cell carcinoma of the lung.
Bernal SD; Mabry M; Stahel RA; Griffin JD; Speak JA
Cancer Res; 1985 Mar; 45(3):1026-32. PubMed ID: 2982482
[TBL] [Abstract][Full Text] [Related]
5. Selective cytotoxicity of murine monoclonal antibody LAM2 against human small-cell carcinoma in the presence of human complement: possible use for in vitro elimination of tumor cells from bone marrow.
Stahel RA; Mabry M; Sabbath K; Speak JA; Bernal SD
Int J Cancer; 1985 May; 35(5):587-92. PubMed ID: 2987136
[TBL] [Abstract][Full Text] [Related]
6. Elimination of clonogenic tumor cells from human bone marrow using a combination of monoclonal antibody:ricin A chain conjugates.
Bregni M; De Fabritiis P; Raso V; Greenberger J; Lipton J; Nadler L; Rothstein L; Ritz J; Bast RC
Cancer Res; 1986 Mar; 46(3):1208-13. PubMed ID: 3510720
[TBL] [Abstract][Full Text] [Related]
7. Complement depletion in vitro limits monoclonal antibody 6-19-dependent complement-mediated killing of tumor cells in bone marrow.
Duerst RE; Rose D; Frantz CN
Exp Hematol; 1991 Oct; 19(9):863-7. PubMed ID: 1893961
[TBL] [Abstract][Full Text] [Related]
8. Serological study for in vitro use of monoclonal antibody for autologous bone marrow transplantation in null cell-type acute lymphocytic leukemia.
Sao H; Morishima Y; Ueda R; Yoshikawa S; Kodera Y; Ohno R; Takahashi T
Jpn J Cancer Res; 1985 Dec; 76(12):1212-21. PubMed ID: 3937833
[TBL] [Abstract][Full Text] [Related]
9. Purging of small cell lung cancer-contaminated bone marrow by monoclonal antibodies and magnetic beads.
Elias AD; Pap SA; Bernal SD
Prog Clin Biol Res; 1990; 333():263-75. PubMed ID: 2155434
[TBL] [Abstract][Full Text] [Related]
10. Preliminary clinical trial of autologous bone marrow transplantation after in vitro monoclonal antibody and complement treatments in null cell-type acute lymphocytic leukemia.
Morishima Y; Sao H; Ueda R; Morishita Y; Murase T; Kodera Y; Ohno R; Tahara T; Yoshikawa S; Kato Y
Jpn J Cancer Res; 1985 Dec; 76(12):1222-9. PubMed ID: 3937834
[TBL] [Abstract][Full Text] [Related]
11. Expression of antigens associated with small cell carcinoma of the lung on hematopoietic progenitor cells.
Ball ED; Keefe KA; Colby E
Cancer Res; 1987 Dec; 47(24 Pt 1):6556-9. PubMed ID: 2824035
[TBL] [Abstract][Full Text] [Related]
12. In vitro treatment of human acute lymphocytic leukemia cells in bone marrow with a cocktail of monoclonal antibodies.
Nakamura H; Hirayama F; Tatsumi Y; Tani Y; Kubota Y; Kanakura Y; Oguma S; Ueda T; Shibata H; Masaoka T
Jpn J Clin Oncol; 1984 Dec; 14 Suppl 1():537-42. PubMed ID: 6596454
[TBL] [Abstract][Full Text] [Related]
13. Elimination of small cell carcinoma of the lung from human bone marrow by monoclonal antibodies and immunomagnetic beads.
Vredenburgh JJ; Ball ED
Cancer Res; 1990 Nov; 50(22):7216-20. PubMed ID: 2171759
[TBL] [Abstract][Full Text] [Related]
14. Use of SM-1 monoclonal antibody and human complement in selective killing of small cell carcinoma of the lung.
Mabry M; Speak JA; Griffin JD; Stahel RA; Bernal SD
J Clin Invest; 1985 May; 75(5):1690-5. PubMed ID: 2987309
[TBL] [Abstract][Full Text] [Related]
15. S-L 11.14: a monoclonal antibody recognizing neuroectodermal tumors with possible value for bone marrow purging before autograft.
Combaret V; Kremens B; Favrot MC; Laurent JC; Philip T
Bone Marrow Transplant; 1988 May; 3(3):221-7. PubMed ID: 2844344
[TBL] [Abstract][Full Text] [Related]
16. Elimination of leukemic cells from human bone marrow using monoclonal antibody and complement.
Bast RC; Ritz J; Lipton JM; Feeney M; Sallan SE; Nathan DG; Schlossman SF
Cancer Res; 1983 Mar; 43(3):1389-94. PubMed ID: 6337707
[TBL] [Abstract][Full Text] [Related]
17. Monoclonal antibodies: the possibilities for cancer therapy.
Poynton CH; Reading CL
Exp Biol; 1984; 43(1):13-33. PubMed ID: 6398221
[TBL] [Abstract][Full Text] [Related]
18. Continuous infusion of complement by an automated cell processor enhances cytotoxicity of monoclonal antibody sensitized leukemia cells.
Howell AL; Fogg-Leach M; Davis BH; Ball ED
Bone Marrow Transplant; 1989 May; 4(3):317-22. PubMed ID: 2659117
[TBL] [Abstract][Full Text] [Related]
19. Cytotoxicity tests against cultured human lung cancer cells with autologous lymphocytes activated in vitro by mitomycin C-treated tumor monolayers in the presence of T-cell growth factor.
Kimura H; Yamaguchi Y; Kadoyama C; Sato N; Fujisawa T
Jpn J Clin Oncol; 1983 Mar; 13(1):3-13. PubMed ID: 6300483
[TBL] [Abstract][Full Text] [Related]
20. Cytotoxic murine monoclonal antibody LAM8 with specificity for human small cell carcinoma of the lung.
Stahel RA; O'Hara CJ; Mabry M; Waibel R; Sabbath K; Speak JA; Bernal SD
Cancer Res; 1986 Apr; 46(4 Pt 2):2077-84. PubMed ID: 3004719
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
